Zymeron Corporation

Zymeron is a research-based biotechnology company that innovates and commercializes healthcare technologies. Founded in 2016, the company operates as an innovation engine to advance portfolios of technologies in biotechnology and healthcare. Zymeron's focus is on discovering, developing, and commercializing innovative technologies to deliver products and solutions with step-change performance in areas such as infectious diseases, immune disorders, emerging threats, and improving the sustainability of critical life support and health maintenance. The company's recent investment of $75.00K came in the form of a grant investment on 22 September 2022. The investment was received from the One North Carolina Small Business Program. This injection of funds is expected to propel Zymeron's efforts in pioneering healthcare technologies and accelerating the development of innovative solutions to address critical medical needs. Zymeron's commitment to disruptive innovation in the biotechnology and healthcare sectors positions it as an attractive prospect for venture capital investment. The company's focus on advancing technologies to detect, prevent, and treat infectious diseases and immune disorders, alongside its emphasis on improving the sustainability of critical life support, underscores its potential for long-term success and impact in the healthcare industry.